Literature DB >> 30061310

The molecular genetic background leading to the formation of the human erythroid-specific Xga/CD99 blood groups.

Chih-Chun Yeh1, Ching-Jin Chang1,2, Yuh-Ching Twu3, Chen-Chung Chu4, Bi-Shan Liu1, Ji-Ting Huang1, Shu-Ting Hung1, Yung-Syu Chan5, Yi-Jui Tsai1, Sheng-Wei Lin2, Marie Lin4,5, Lung-Chih Yu1,2.   

Abstract

The Xga and CD99 antigens of the human Xg blood group system show a unique and sex-specific phenotypic relationship. The phenotypic relationship is believed to result from transcriptional coregulation of the XG and CD99 genes, which span the pseudoautosomal boundary of the X and Y chromosomes. However, the molecular genetic background responsible for these blood groups has remained undetermined. During the present investigation, we initially conducted a pilot study aimed at individuals with different Xga/CD99 phenotypes; this used targeted next-generation sequencing of the genomic areas relevant to XG and CD99 This was followed by a large-scale association study that demonstrated a definite association between a single nucleotide polymorphism (SNP) rs311103 and the Xga/CD99 blood groups. The G and C genotypes of SNP rs311103 were associated with the Xg(a+)/CD99H and Xg(a-)/CD99L phenotypes, respectively. The rs311103 genomic region with the G genotype was found to have stronger transcription-enhancing activity by reporter assay, and this occurred specifically with erythroid-lineage cells. Such activity was absent when the same region with the C genotype was investigated. In silico analysis of the polymorphic rs311103 genomic regions revealed that a binding motif for members of the GATA transcription factor family was present in the rs311103[G] region. Follow-up investigations showed that the erythroid GATA1 factor is able to bind specifically to the rs311103[G] region and markedly stimulates the transcriptional activity of the rs311103[G] segment. The present findings identify the genetic basis of the erythroid-specific Xga/CD99 blood group phenotypes and reveal the molecular background of their formation.
© 2018 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30061310      PMCID: PMC6093725          DOI: 10.1182/bloodadvances.2018018879

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  51 in total

1.  Identification and immunochemical characterization of the human erythrocyte membrane glycoproteins that carry the Xga antigen.

Authors:  R Herron; G A Smith
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

2.  A sex-linked blood group.

Authors:  J D MANN; A CAHAN; A G GELB; N FISHER; J HAMPER; P TIPPETT; R SANGER; R R RACE
Journal:  Lancet       Date:  1962-01-06       Impact factor: 79.321

3.  The 12E7 red cell quantitative polymorphism: control by the Y-borne locus, Yg.

Authors:  P Tippett; M A Shaw; C A Green; G L Daniels
Journal:  Ann Hum Genet       Date:  1986-10       Impact factor: 1.670

4.  The X-linked blood group system Xg. Tests on unrelated people and families of northern European ancestry.

Authors:  R Sanger; P Tippett; J Gavin
Journal:  J Med Genet       Date:  1971-12       Impact factor: 6.318

5.  Testing Departure from Hardy-Weinberg Proportions.

Authors:  Jian Wang; Sanjay Shete
Journal:  Methods Mol Biol       Date:  2017

6.  A new PKLR gene mutation in the R-type promoter region affects the gene transcription causing pyruvate kinase deficiency.

Authors:  L Manco; M L Ribeiro; V Máximo; H Almeida; A Costa; O Freitas; J Barbot; A Abade; G Tamagnini
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

Review 7.  Ldb1 complexes: the new master regulators of erythroid gene transcription.

Authors:  Paul E Love; Claude Warzecha; LiQi Li
Journal:  Trends Genet       Date:  2013-11-27       Impact factor: 11.639

8.  Mouse CD99 participates in T-cell recruitment into inflamed skin.

Authors:  Gabriele Bixel; Stephan Kloep; Stefan Butz; Björn Petri; Britta Engelhardt; Dietmar Vestweber
Journal:  Blood       Date:  2004-07-27       Impact factor: 22.113

9.  X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutations.

Authors:  Dean R Campagna; Charlotte I de Bie; Klaus Schmitz-Abe; Marion Sweeney; Anoop K Sendamarai; Paul J Schmidt; Matthew M Heeney; Helger G Yntema; Caroline Kannengiesser; Bernard Grandchamp; Charlotte M Niemeyer; Nine V A M Knoers; Sonia Swart; Gordon Marron; Richard van Wijk; Reinier A Raymakers; Alison May; Kyriacos Markianos; Sylvia S Bottomley; Dorine W Swinkels; Mark D Fleming
Journal:  Am J Hematol       Date:  2013-11-20       Impact factor: 10.047

10.  Endothelial CD99 signals through soluble adenylyl cyclase and PKA to regulate leukocyte transendothelial migration.

Authors:  Richard L Watson; Jochen Buck; Lonny R Levin; Ryan C Winger; Jing Wang; Hisashi Arase; William A Muller
Journal:  J Exp Med       Date:  2015-06-22       Impact factor: 14.307

View more
  4 in total

1.  Major sex differences in allele frequencies for X chromosomal variants in both the 1000 Genomes Project and gnomAD.

Authors:  Zhong Wang; Lei Sun; Andrew D Paterson
Journal:  PLoS Genet       Date:  2022-05-31       Impact factor: 6.020

Review 2.  Banking with precision: transfusion medicine as a potential universal application in clinical genomics.

Authors:  Celina Montemayor; Patricia A R Brunker; Margaret A Keller
Journal:  Curr Opin Hematol       Date:  2019-11       Impact factor: 3.284

3.  Defining Blood Group Gene Reference Alleles by Long-Read Sequencing: Proof of Concept in the ACKR1 Gene Encoding the Duffy Antigens.

Authors:  Yann Fichou; Isabelle Berlivet; Gaëlle Richard; Christophe Tournamille; Lilian Castilho; Claude Férec
Journal:  Transfus Med Hemother       Date:  2019-12-11       Impact factor: 3.747

4.  Association of Maternal Regulatory Single Nucleotide Polymorphic CD99 Genotype with Preeclampsia in Pregnancies Carrying Male Fetuses in Ethiopian Women.

Authors:  Tsehayneh Kelemu; Lena Erlandsson; Daniel Seifu; Markos Abebe; Sisay Teklu; Jill R Storry; Stefan R Hansson
Journal:  Int J Mol Sci       Date:  2020-08-14       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.